Skip to Content

Notice

Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the agency's Division of Dockets Management.

ADDRESSES:

Submit written requests for copies of summaries of safety and effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Nicole Wolanski, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1650, Silver Spring, MD 20993-0002, 301-796-6570.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:Start Printed Page 54155

I. Background

In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule that revised 21 CFR 814.44(d) and 814.45(d) to discontinue individual publication of PMA approvals and denials in the Federal Register. Instead, the agency now posts this information on the Internet on FDA's home page at http://www.fda.gov. FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.

In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.

The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from April 1, 2010, through June 30, 2010. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.

Table 1.—List of Safety and Effectiveness Summaries for Approved PMAs Made Available From April 1, 2010, through June 30, 2010

PMA No. Docket No.ApplicantTRADE NAMEApproval Date
P090018 FDA-2010-M-0244Envoy Medical Corp.ESTEEM TOTALLY IMPLANTABLE HEARING SYSTEMMarch 17, 2010
P080029 FDA-2010-M-0220Interventional Therapies, LLCQUICK CLOSE VASCULAR SUTURING SYSTEMApril 8, 2010
P090022 FDA-2010-M-0219Lenstec, Inc.SOFTEC HD POSTERIOR CHAMBER INTRAOCULAR LENS (PCIOL)April 12, 2010
P080032 FDA-2010-0242Asthmatix, Inc.ALAIR BRONCHIAL THERMOPLASTYApril 27, 2010
P090007 FDA-2010-M-0261Roche Diagnostics Corp.ELECSYS ANTI-HCV IMMUNOASSAY AND ELECSYS PRECICONTROL ANTI-HCV FOR USE ON THE COBAS E411 IMMUNOASSAY ANALYZERApril 29, 2010
P090008 FDA-2010-M-0262Roche Diagnostics Corp.ELECSYS ANTI-HCV IMMUNOASSAY AND ELECSYS PRECICONTROL ANTI-HCV FOR USE ON THE COBAS E601 IMMUNOASSAY ANALYZERApril 29, 2010
P090009 FDA-2010-M-0264Roche Diagnostics Corp.ELECSYS ANTI-HCV IMMUNOASSAY AND ELECSYS PRECICONTROL ANTI-HCV FOR USE ON THE MODULAR ANALYTICS E170 ANALYZERApril 29, 2010
P050027 FDA-2010-M-0294Karl Storz endoscopy—America, Inc.PHOTODYNAMIC DIAGNOSTIC D-LIGHT CMay 28, 2010
P060029 FDA-2010-M-0285Ethicon, Inc.OMNEX SURGICAL SEALANTJune 3, 2010

II. Electronic Access

Persons with access to the Internet may obtain the documents at http://www.fda.gov/​cdrh/​pmapage.html.

Start Signature

Dated: August 31, 2010.

Nancy K. Stade,

Deputy Director for Policy, Center for Devices and Radiological Health.

End Signature End Supplemental Information

[FR Doc. 2010-22085 Filed 9-2-10; 8:45 am]

BILLING CODE 4160-01-S